Overview
Secondary syphilis can manifest with cutaneous manifestations, including anetoderma, characterized by localized skin atrophy often associated with inflammatory infiltrates. 1Diagnosis
Skin biopsy revealing inflammatory cells, particularly T-helper cells (anti-Leu-3a antibody positive), and occasional suppressor T-cells (anti-Leu-1 antibody positive). 1
Presence of monocyte infiltration (OKM1 antibody positive cells) may be observed. 1
Consider atypical associations such as Jadassohn-type anetoderma with ocular conditions like keratoconus and cataracts in differential diagnosis. 2Management
First-line treatment: Penicillin G, typically benzathine penicillin 2.4 million units intramuscularly in a single dose for primary and secondary syphilis. [Not explicitly detailed in abstracts, standard clinical practice]
Adjunctive treatments: Topical corticosteroids may be used for symptomatic relief of inflammatory skin lesions, though evidence from abstracts is limited. [Not explicitly detailed in abstracts, standard clinical practice]Special Populations
Comorbidities: No specific guidance provided for comorbidities like ocular conditions (keratoconus, cataracts) associated with anetoderma. 2
Pregnancy: Management typically involves adjusting penicillin dosing to avoid toxicity; consult specific obstetric guidelines. [Not explicitly detailed in abstracts, standard clinical practice]
Pediatrics: Dosage adjustments for pediatric patients are necessary; consult pediatric infectious disease guidelines. [Not explicitly detailed in abstracts, standard clinical practice]
Elderly: Consider potential renal function impacts on penicillin dosing; monitor closely. [Not explicitly detailed in abstracts, standard clinical practice]Key Recommendations
Perform skin biopsy for confirmation, focusing on T-cell subset analysis and inflammatory cell presence for diagnosis of secondary syphilis-related anetoderma. (Evidence: Moderate 1)
Initiate treatment with benzathine penicillin for secondary syphilis, adjusting as necessary for special populations like pregnancy or renal impairment. (Evidence: Expert opinion)
Monitor for atypical associations such as ocular conditions in patients with Jadassohn-type anetoderma for comprehensive management. (Evidence: Weak 2)References
1 Venencie PY, Winkelmann RK. Monoclonal antibody studies in the skin lesions of patients with anetoderma. Archives of dermatology 1985. link
2 Brenner S, Nemet P, Legum C. Jadassohn-type anetoderma in association with keratoconus and cataract. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 1977. link